Abstract
A nerve is composed of axon (neural tissue) and connective tissue. Each axon in myelinated nerve fibers is surrounded by the endoneurium. Groups of nerve fibers form fascicles, surrounded by the perineurium, and groups of fascicles are surrounded by the internal and external epineurium. Impairments of the peripheral nervous system (PNS) lead to peripheral neuropathies that could be whether acquired (traumatic, drug toxicity, infection, etc.) or inherited, due to genetic abnormalities.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Salih MA. Peripheral nerve disorders. In: Textbook of clinical pediatrics. Berlin: Springer; 2012. p. 3475–91.
Jung KH, Hyun PS. Sciatic nerve injection injury. J Int Med Res. 2014;42(4):887–97.
Namate C, Shabana M, Mumba P, Chimangeni S, Prime M, Cashman J. Aetiology of acquired ‘drop foot’ deformity in Malawian children: a case series of 50 patients. Trop Doct. 2012;42(4):229.
Griffith AH. The role of immunization in the control of diphtheria. Dev Biol Stand. 1979;43:3–13.
Byard RW. Diphtheria—‘The strangling angel’ of children. J Forensic Leg Med. 2013;20(2):65–8.
Kanwal SK, Yadav D, Chhapola V, Kumar V. Post-diphtheritic neuropathy: a clinical study in paediatric intensive care unit of a developing country. Trop Doct. 2012;42(4):195–7.
Manikyamba D, Satyavani A, Deepa P. Diphtheritic polyneuropathy in the wake of resurgence of diphtheria. J Pediatr Neurosci. 2014;10(4):331–4.
Mateen FJ, Bahl S, Khera A, Sutter RW. Detection of diphtheritic polyneuropathy by acute flaccid paralysis surveillance. India Emerg Infect Dis. 2013;19(9):1368–73.
Zasada A. Corynebacterium diphtheriae infections currently and in the past. Przegl Dermatol. 2014;69(3):439–44.
Jablonka A, Behrens GM, Stange M, Dopfer C, Grote U, Hansen G, Schmidt RE, Happle C. Tetanus and diphtheria immunity in refugees in Europe in 2015. Infection. 2016;19:1–8.
Salih MAM, Suliman GI, Hassan HS. Complications of diphtheria seen during the 1978 outbreak in Khartoum. Ann Trop Paediatr. 1981;1:97–101.
Salih MAM, Suliman GI, Hassan HS. Unusual sites of diphtheritic membrane and cervical oedema. SudanJPaediatr. 1984;3:52–62.
Salih MAM. A clinical profile of diphtheria in Sudanese children. Sudan J Paediatr. 1986;5:31–6.
Salih MAM, El Hakeem HS, Suliman GI, Khatim AS. An epidemiological study of the 1978 outbreak of diphtheria in Khartoum province. J Trop Pediatr. 1985;31:8–12.
Logina I, Donaghy M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 1999;67(4):433–8.
Loevinsohn BP. The changing age structure of diphtheria patients: evidence for the effectiveness of EPI in the Sudan. Bull World Health Organ. 1990;68(3):353–7.
WHO—World Health Organization. Weekly epidemiological record; WHO [Internet] 2015, n° 36, 90th year, p. 461–476. Washington: The Organization. http://www.who.int/wer/2015/wer9036.pdf. Accessed 7 Oct 2016.
Santos SD, Penna GO, Costa MD, Natividade MS, Teixeira MG. Leprosy in children and adolescents under 15 years old in an urban centre in Brazil. Mem Inst Oswaldo Cruz. 2016;111(6):359–64.
Schreuder PA, Noto S, Richardus JH. Epidemiologic trends of leprosy for the 21st century. Clin Dermatol. 2016;34:24–31.
Cook MJ. Lyme borreliosis: a review of data on transmission time after tick attachment. Int J Gen Med. 2015;8:1–8. https://doi.org/10.2147/IJGM.S73791.
Centers for Disease Control and Prevention (CDC). Lyme disease data. September 24, 2015. http://www.cdc.gov/lyme/stats/index.html?s_cid=cs_281. Accessed 8 Oct 2016.
Centers for Disease Control and Prevention (CDC). Lyme disease—United States, 2003–2005. Morb Mortal Wkly Rep. 2007;56(23):573.
Huppertz HI. Childhood Lyme borreliosis in Europe. Eur J Pediatr. 1990;149(12):814–21.
Hehir MK 2nd, Logigian EL. Infectious neuropathies. Continuum (Minneapolis, Minn.). 2014;20(5 Peripheral Nervous System Disorders):1274–92.
Agarwal R, Sze G. Neuro-lyme disease: MR imaging findings. Radiology. 1999;253:167–73.
Dersch R, Hottenrott T, Schmidt S, Sommer H, Huppertz HI, Rauer S, Meerpohl JJ. Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review. BMC Neurol. 2016;16(1):189.
Hendaus MA, Qaqish RM, Alhammadi AH. Neurobrucellosis in children. Asian Pac J Trop Biomed. 2015;5(2):158–61.
Salih MA, Abdel-Gader AM, Al-Jarallah AA, Kentab AY, Gadelrab MO, Alorainy IA, et al. Infectious and inflammatory disorders of the circulatory systems as risk factors for stroke in Saudi children. Saudi Med J. 2006;27(Suppl 1):S41–52.
Wilmshurst JM. Diagnosis and management of pediatric peripheral neuropathies in resource-poor settings. Future Neurol. 2013;8(2):133–48.
Kandula T, Park SB, Cohn RJ, Krishnan AV, Farrar MA. Pediatric chemotherapy induced peripheral neuropathy: a systematic review of current knowledge. Cancer Treat Rev. 2016;50:118–28.
Lavoie SE, Li L, Chiang C, Thomas K, Hutchinson RJ, Wells EM, et al. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. J Peripher Nerv Syst. 2015;20(1):37–46.
Lanphear BP, Lowry JA, Ahdoot S, Baum CR, Bernstein AS, Bole A, et al. Prevention of childhood lead toxicity. Pediatrics. 2016;20:e20161493.
Hamad MH, Adeel AA, Alhaboob AAN, Ashri AM, Salih MA. Acute poisoning in a child following topical treatment of head lice (pediculosis capitis) with an organophosphate pesticide. Sudan J Paediatr. 2016;16(1):63–6.
Madhusudanan M, Menon MK, Ummer K, Radhakrishnanan K. Clinical and etiological profile of tropical ataxic neuropathy in Kerala. South India Eur Neurol. 2007;60(1):21–6.
BMJ Best Practice. Guillain Barre Syndrome. 2016 http://bestpractice.bmj.com/best-practice/monograph-pdf/176.pdf. Accessed 13 Oct 2016.
Roodbol J, de Wit MC, Walgaard C, de Hoog M, Catsman-Berrevoets CE, Jacobs BC. Recognizing Guillain-Barre syndrome in preschool children. Neurology. 2011;76(9):807–10.
Dimachkie MM, Barohn RJ. Guillain-Barre syndrome and variants. Neurol Clin. 2013;31(2):491–510.
Babiker MOE. The boy who stopped walking. Sudan J Paediatr. 2015;15(1):65–8.
Nishimoto Y, Susuki K, Yuki N. Serologic marker of acute motor axonal neuropathy in childhood. Pediatr Neurol. 2008;39(1):67–70.
Schessl J, Koga M, Funakoshi K, Kirschner J, Muellges W, Weishaupt A, et al. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome. Arch Dis Child. 2007;92(1):48–52.
Maloney JA, Mirsky DM, Messacar K, Dominguez SR, Schreiner T, Stence NV. MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak. Am J Neuroradiol. 2015;36(2):245–50.
Adeel AAA. Spinal cord schistosomiasis. Sudan J Paediatr. 2015;15(2):23–8.
Hughes RAC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2014;(9):CD002063. https://doi.org/10.1002/14651858.CD002063.pub6.
Hughes RAC, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2012;(8):CD001446. https://doi.org/10.1002/14651858.CD001446.pub4.
Korinthenberg R, Schessl J, Kirschner J, Mönting JS. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial. Pediatrics. 2005;116(1):8–14.
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. The Lancet. 2016;388(10045):717–27.
Finsterer J. Systemic and non-systemic vasculitis affecting the peripheral nerves. Acta Neurol Belg. 2009;109(2):100–13.
Blaes F. Diagnosis and therapy for peripheral vasculitic neuropathy. In: Systemic vasculitides: current status and perspectives 2016. Cham: Springer International Publishing; 2016. p. 259–80.
Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol. 2005;252(6):633–41.
Agadi JB, Raghav G, Mahadevan A, Shankar SK. Usefulness of superficial peroneal nerve/peroneus brevis muscle biopsy in the diagnosis of vasculitic neuropathy. J Clin Neurosci. 2012;19(10):1392–6.
Blaes F. Diagnosis and therapeutic options for peripheral vasculitic neuropathy. Ther Adv Musculoskelet Dis. 2015;7(2):45–55. https://doi.org/10.1177/1759720X14566617.
Azzedine H, Senderek J, Rivolta C, Chrast R. Molecular genetics of charcot-marie-tooth disease: from genes to genomes. Mol Syndromol. 2012;3(5):204–14. https://doi.org/10.1159/000343487. Epub 2012 Oct 12
Azzedine H, Durosier G, Tazir M, et al. Autosomal recessive Charcot-Marie-Tooth families linked to the 1q21 locus. 51st annual meeting of the American Society of Human Genetics, San Diego (USA): 13th–18th October 2001. Abstract in: Am J Hum Genet 2001;69(Suppl):1911.
Mathis S, Goizet C, Tazir M, Magdelaine C, Lia AS, Magy L, Vallat JM. Charcot-Marie-Tooth diseases: an update and some new proposals for the classification. J Med Genet. 2015;52(10):681–90.
Barreto LC, Oliveira FS, Nunes PS, de França CI, Garcez CA, Goes GM, Neves EL, de Souza SQ, de Souza AA. Epidemiologic study of Charcot-Marie-Tooth disease: a systematic review. Neuroepidemiology. 2016;46(3):157–65.
Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clin Genet. 1974;6(2):98–118.
Martin JJ, Brice A, Van Broeckhoven C. 4th workshop of the European CMT-Consortium—62nd ENMC international workshop: rare forms of Charcot-Marie-Tooth disease and related disorders. 16–18 October 1998, Soestduinen, The Netherlands. Neuromuscul Disord. 1999;9(4):279–87.
Laššuthová P, ŠafkaBrožková D, Krůtová M, et al. Improving diagnosis of inherited peripheral neuropathies through gene panel analysis. Orphanet J Rare Dis. 2016;11(1):118. https://doi.org/10.1186/s13023-016-0500-5.
Ylikallio E, Woldegebriel R, Tumiati M, Isohanni P, Ryan MM, Stark Z, Walsh M, Sawyer SL, Bell KM, Oshlack A, Lockhart PJ, Shcherbii M, Estrada-Cuzcano A, Atkinson D, Hartley T, Tetreault M, Cuppen I, van der Pol WL, Candayan A, Battaloglu E, Parman Y, van Gassen KLI, van den Boogaard MH, Boycott KM, Kauppi L, Jordanova A, Lönnqvist T, Tyynismaa H. MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability. Brain. 2017;140(8):2093–103.
Karakaya M, Mazaheri N, Polat I, Bharucha-Goebel D, Donkervoort S, Maroofian R, Shariati G, Hoelker I, Monaghan K, Winchester S, Zori R, Galehdari H, Bönnemann CG, Yis U, Wirth B. Biallelic MCM3AP mutations cause Charcot-Marie-Tooth neuropathy with variable clinical presentation. Brain. 2017;140(10):e65. https://doi.org/10.1093/brain/awx222.
Baets J, Deconinck T, De Vriendt E, Zimon M, Yperzeele L, Van Hoorenbeeck K, et al. Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain. 2011;134:266476.
Bird TD. Charcot-Marie-Tooth Hereditary Neuropathy Overview. 1998 Sep 28 [Updated 2016 Sep 1]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. 2016. https://www.ncbi.nlm.nih.gov/books/NBK1358/
Bird TD. Hereditary Neuropathy with Liability to Pressure Palsies. 1998 Sep 28 [Updated 2014 Sep 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle;1993–2016. 2014. https://www.ncbi.nlm.nih.gov/books/NBK1392/
Azzedine H, Ravisé N, Verny C, Gabrëels-Festen A, Lammens M, Grid D, Vallat JM, Durosier G, Senderek J, Nouioua S, Hamadouche T, Bouhouche A, Guilbot A, Stendel C, Ruberg M, Brice A, Birouk N, Dubourg O, Tazir M, LeGuern E. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology. 2006;67(4):602–6.
Bouhouche A, Birouk N, Azzedine H, Benomar A, Durosier G, Ente D, Muriel MP, Ruberg M, Slassi I, Yahyaoui M, Dubourg O, Ouazzani R, LeGuern E. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families. Brain. 2007;130(Pt 4):1062–75.
Gabreëls-Festen A, van Beersum S, Eshuis L, LeGuern E, Gabreëls F, van Engelen B, Mariman E. Study on the gene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33. J Neurol Neurosurg Psychiatry. 1999;66(5):569–74.
Kessali M, Zemmouri R, Guilbot A, Maisonobe T, Brice A, LeGuern E, Grid D. A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease. Neurology. 1997;48(4):867–73.
Tazir M, Azzedine H, Assami S, Sindou P, Nouioua S, Zemmouri R, Hamadouche T, Chaouch M, Feingold J, Vallat JM, Leguern E, Grid D. Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C. Brain. 2004;127(Pt 1):154–63.
Weis J, Claeys KG, Roos A, Azzedine H, Katona I, Schröder JM, Senderek J. Towards a functional pathology of hereditary neuropathies. Acta Theriol. 2017;133(4):493–515.
Dubourg O, Azzedine H, Verny C, Durosier G, Birouk N, Gouider R, Salih M, Bouhouche A, Thiam A, Mayer M, Ruberg M. Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease. Neuromol Med. 2006;8(1–2):75–85.
Wilmshurst JM, Ouvrier R. Hereditary peripheral neuropathies of childhood: an overview for clinicians. Neuromuscul Disord. 2011;21(11):763–75.
Azzedine H, LeGuern E, Salih MA. Charcot-Marie-Tooth Neuropathy Type 4C. 2008 Mar 31 (Updated 2015 Oct 15]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. https://www.ncbi.nlm.nih.gov/books/NBK1340/
Cogli L, Piro F, Bucci C. Rab7 and the CMT2B disease. Biochem Soc Trans. 2009;37(Pt 5):1027–31.
Bird TD. Charcot-Marie-Tooth Neuropathy Type 1. 1998 Aug 31 [Updated 2015 Mar 26]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. 2015. https://www.ncbi.nlm.nih.gov/books/NBK1205/
Chrestian N, McMillan H, Poulin C, Campbell C, Vajsar J. Hereditary neuropathy with liability to pressure palsies in childhood: case series and literature update. Neuromuscul Disord. 2015;25(9):693–8.
Azzedine H, Ruberg M, Ente D, Gilardeau C, Périé S, Wechsler B, Brice A, LeGuern E, Dubourg O. Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene. Neuromuscul Disord. 2003;13(4):341–6.
Sevilla T, Jaijo T, Nauffal D, Collado D, Chumillas MJ, Vilchez JJ, Muelas N, Bataller L, Domenech R, Espinós C, Palau F. Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy. Brain. 2008;131:3051–61.
Bolino A, Levy ER, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou RK, Hausmanowa-Petrusewicz I, Mandich P, Gambardella A. Genetic refinement and physical mapping of the CMT4B gene on chromosome 11q22. Genomics. 2000;63(2):271–8.
Bolino A, Muglia M, Conforti FL, et al. Charcot-Marie-Tooth type4B is caused by mutations in the gene encoding myotubularin-related protein 2. Nat Genet. 2000;25:17–9.
Salih MA, Maisonobe T, Kabiraj M, Al Rayess M, Al-Turaiki MH, Akbar M, Tahan A, Urtizberea JA, Hamadouche T, Guilbot A, Brice A. Autosomal recessive hereditary neuropathy with focally folded myelin sheaths and linked to chromosome 11q23: a distinct and homogeneous entity. Neuromuscul Disord. 2000;10(1):10–5.
Azzedine H, Bolino A, Taïeb T, Birouk N, Di Duca M, Bouhouche A, Benamou S, Mrabet A, Hammadouche T, Chkili T, Gouider R, Ravazzolo R, Brice A, Laporte J, LeGuern E. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet. 2003;72(5):1141–53.
Alazami AM, Alzahrani F, Bohlega S, Alkuraya FS. SET binding factor 1 (SBF1) mutation causes Charcot-Marie-tooth disease type 4B3. Neurology. 2014;82:1665–6.
Siskind CE, Panchal S, Smith CO, Feely SM, Dalton JC, Schindler AB, Krajewski KM. A review of genetic counseling for Charcot Marie Tooth disease (CMT). J Genet Couns. 2013;22(4):422–36. https://doi.org/10.1007/s10897-013-9584-4. Epub 2013 April 21. Review
Alazami AM, Patel N, Shamseldin HE, Anazi S, Al-Dosari MS, Alzahrani F, et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. Cell Rep. 2015;10:148–61.
Alkuraya FS. Impact of new genomic tools on the practice of clinical genetics in consanguineous populations: the Saudi experience. Clin Genet. 2013;84(3):203–8.
Azzedine H, Zavadakova P, Planté-Bordeneuve V, Vaz Pato M, Pinto N, Bartesaghi L, Zenker J, Poirot O, Bernard-Marissal N, Arnaud Gouttenoire E, Cartoni R, Title A, Venturini G, Médard JJ, Makowski E, Schöls L, Claeys KG, Stendel C, Roos A, Weis J, Dubourg O, Leal Loureiro J, Stevanin G, Said G, Amato A, Baraban J, LeGuern E, Senderek J, Rivolta C, Chrast R. PLEKHG5 deficiency leads to an intermediate form of autosomal-recessive Charcot-Marie-Tooth disease. Hum Mol Genet. 2013;22(20):4224–32.
Spagnoli C, Iodice A, Salerno GG, Frattini D, Bertani G, Fusco C. Hereditary neuropathy with liability to pressure palsies in childhood: Case series and literature update. Neuromuscul Disord. 2016;26(6):394.
Kararizou E, Karandreas N, Davaki P, Davou R, Vassilopoulos D. Polyneuropathies in teenagers: a clinicopathological study of 45 cases. Neuromuscul Disord. 2006;16(5):304–7.
Mehta A, Hughes DA. Fabry disease. 2002 Aug 5 [Updated 2017 Jan 5]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. https://www.ncbi.nlm.nih.gov/books/NBK1292/
Kraemer KH, DiGiovanna JJ. Xeroderma pigmentosum. 2003 Jun 20 [Updated 2016 Sep 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. https://www.ncbi.nlm.nih.gov/books/NBK1397/
Hijazi H, Salih MA, Hamad MH, Hassan HH, Salih SB, Mohamed KA, Mukhtar MM, Karrar ZA, Ansari S, Ibrahim N, Alkuraya FS. Pellagra-like condition is xeroderma pigmentosum/Cockayne syndrome complex and niacin confers clinical benefit. Clin Genet. 2014;87(1):56–61.
Natale V, Raquer H. Xeroderma pigmentosum-Cockayne syndrome complex. Orphanet J Rare Dis. 2017;12:65.
Chessa L, Micheli R, Molinaro A. Focusing new ataxia telangiectasia therapeutic approaches. J Rare Dis Diagn Ther. 2016;2:2.
Fernet M, Gribaa M, Salih MA, Seidahmed MZ, Hail J, Koenig M. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet. 2005;14:307–18.
Takashima H, Boerkoel CF, John J, Saifi GM, Salih MA, Armstrong D, Mao Y, Quiocho FA, Roa BB, Nakagawa M, Stockton DW. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet. 2002;32(2):267–72.
Anheim M, Monga B, Fleury M, Charles P, Barbot C, Salih M, Delaunoy JP, Fritsch M, Arning L, Synofzik M, Schöls L. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain. 2009;132(Pt 10):2688–98.
Ramchandren S. Charcot-Marie-Tooth disease and other genetic polyneuropathies. Continuum (Minneap Minn). 2017;23(5):1360–77.
Salih MA, Mundwiller E, Khan AO, AlDrees A, Elmalik SA, Hassan HH, Al-Owain M, Alkhalidi HM, Katona I, Kabiraj MM, Chrast R, Kentab AY, Alzaidan H, Rodenburg RJ, Bosley TM, Weis J, Koenig M, Stevanin G, Azzedine H. New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations. PLoS One. 2013;8(10):e76831.
Rossor AM, Evans MR, Reilly MM. A practical approach to the genetic neuropathies. Pract Neurol. 2015;15(3):187–98.
Vallat JM, Funalot B, Magy L. Nerve biopsy: requirements for diagnosis and clinical value. Acta Neuropathol. 2011;121(3):313–26.
Liao JP, Waclawik AJ. Nerve root hypertrophy in CMT type 1A. Neurology. 2004;62(5):783.
Goedee HS, Brekelmans GJ, van Asseldonk JT, Beekman R, Mess WH, Visser LH. High resolution sonography in the evaluation of the peripheral nervous system in polyneuropathy—a review of the literature. Eur J Neurol. 2013;20(10):1342–51.
Walker FO. Ultrasonography in peripheral nervous system diagnosis. Continuum (Minneap Minn). 2017;23(5):1276–94.
Gaeta M, Mileto A, Mazzeo A, Minutoli F, Di Leo R, Settineri N, et al. MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot-Marie-Tooth type 2 F disease. Skeletal Radiol. 2012;41(5):515–24.
Kuhlenbäumer G, Timmerman V, Bomont P. Giant axonal neuropathy. 2003 Jan 9 [Updated 2014 Oct 9]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. https://www.ncbi.nlm.nih.gov/books/NBK1136/
Rudnik-Schöneborn S, Auer-Grumbach M, Senderek J. Hereditary neuropathies: update 2017. Neuropediatrics. 2017;48(4):282–93.
Salih MA, Ahlsten G, Stålberg E, Schmidt R, Sunnegårdh J, Michaelsson M, Gamstorp I. Friedreich’s ataxia in 13 children: presentation and evolution with neurophysiologic, electrocardiographic, and echocardiographic features. J Child Neurol. 1990;5(4):321–6.
Fridman V, Bundy B, Reilly MM, Pareyson D, Bacon C, Burns J, Day J, Feely S, Finkel RS, Grider T, Kirk CA. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry. 2015;86(8):873–8.
Anazi S, Maddirevula S, Faqeih E, Alsedairy H, Alzahrani F, Shamseldin HE, et al. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield. Mol Psychiatry. 2017;22(4):615–24.
Anazi S, Maddirevula S, Salpietro V, Asi YT, Alsahli S, Alhashem A, et al. Expanding the genetic heterogeneity of intellectual disability. Hum Genet. 2017;136(11–12):1419–29.
Monies D, Abouelhoda M, AlSayed M, Alhassnan Z, Alotaibi M, Kayyali H, et al. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes. Hum Genet. 2017;9:1–9.
Maystadt I, Zarhrate M, Leclair-Richard D, Estournet B, Barois A, Renault F, Routon MC, Durand MC, Lefebvre S, Munnich A, Verellen-Dumoulin C, Viollet L. A gene for an autosomal recessive lower motor neuron disease with childhood onset maps to 1p36. Neurology. 2006;67:120–4.
Maystadt I, Rezsöhazy R, Barkats M, Duque S, Vannuffel P, Remacle S, Lambert B, Najimi M, Sokal E, Munnich A, Viollet L, Verellen-Dumoulin C. The nuclear factor κB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am J Hum Genet. 2007;81:67–76.
Dowling JJ, Gonorazky HD, Cohn RD, Campbell C. Treating pediatric neuromuscular disorders: the future is now. Am J Med Genet A. 2018;176(4):804–41.
Pareyson D, Saveri P, Pisciotta C. New developments in Charcot–Marie–Tooth neuropathy and related diseases. Curr Opin Neurol. 2017;30(5):471–80.
Lee H-S, Kim MJ, Ko DS, Jeon EJ, Kim JY, Kang IS. Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease. Clin Exp Reprod Med. 2013;40(4):163–8. https://doi.org/10.5653/cerm.2013.40.4.163.
Dyck PJ. Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. Philadelphia: W.B. Saunders; 1993. p. 1065–93.
Davidson G, Murphy S, Polke J, Laura M, Salih M, Muntoni F, Blake J, Brandner S, Davies N, Horvath R, Price S. Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. J Neurol. 2012;259(8):1673–85.
Mroczek M, Kabzińska D, Kochański A. Molecular pathogenesis, experimental therapy and genetic counseling in hereditary sensory neuropathies. Acta Neurobiol Exp. 2014;75(2):126–43.
Othman SA, Malik AA. Congenital insensitivity to pain with anhidrosis in Sudanese children. Sudanese J Paediatr. 2016;16(2):80–5.
Pérez-López LM, Cabrera-González M, Gutiérrez-de la Iglesia D, Ricart S, Knörr-Giménez G. Update review and clinical presentation in congenital insensitivity to pain and anhidrosis. Case Rep Pediatr. 2015;2015:589852.
Houlden H, King R, Blake J, Groves M, Love S, Woodward C, Hammans S, Nicoll J, Lennox G, O'Donovan DG, Gabriel C. Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I). Brain: a journal of neurology. 2006;129(Pt 2):411–25.
Chen Y-C, Auer-Grumbach M, Matsukawa S, Zitzelsberger M, Themistocleous AC, Strom TM, Samara C, Moore AW, Cho LT-Y, Young GT, Weiss C, Schabhuttl M, et al. Transcriptional regulator PRDM12 is essential for human pain perception. Nat Genet. 2015;47:803–8.
Kurth I. Hereditary sensory and autonomic neuropathy type II. 2010 Nov 23 [Updated 2015 Feb 19]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. https://www.ncbi.nlm.nih.gov/books/NBK49247/
Edvardson S, Cinnamon Y, Jalas C, Shaag A, Maayan C, Axelrod FB, Elpeleg O. Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol. 2012;71:569–72.
Leipold E, Liebmann L, Korenke GC, Heinrich T, Giesselmann S, Baets J, Ebbinghaus M, Goral RO, Stodberg T, Hennings JC, Bergmann M, Altmuller J, et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet. 2013;45:1399–404.
Zhang S, Sharif SM, Chen Y-C, Valente E-M, Ahmed M, Sheridan E, Bennett C, Woods G. Clinical features for diagnosis and management of patients with PRMD12 congenital insensitivity to pain. J Med Genet. 2016;53:533–5.
Bouhouche A, Benomar A, Bouslam N, Chkili T, Yahyaoui M. Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia. J Med Genet. 2006;43(5):441–3. https://doi.org/10.1136/jmg.2005.039230.
Lee MJ, Stephenson DA, Groves MJ, Sweeney MG, Davis MB, An SF, Houlden H, Salih MA, Timmerman V, de Jonghe P, Auer-Grumbach M. Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4) gene. Hum Mol Genet. 2003;12(15):1917–25.
Axelrod FB, Gold-von SG. Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet J Rare Dis. 2007;2:39.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
41.1 Electronic Supplementary Material
A 4-year-old girl, with acute lymphoblastic leukemia (ALL), who developed toxicity following vincristine therapy (Fig. 41.3a, b). She could walk after 7 months, and the video, taken 9 months later, shows normal gait (MOV 17021 kb)
Resuming normal gait in a 10-year-old boy who had Guillain-Barré syndrome a year ago. During the acute illness, he required ventilation for 22 days (AVI 2441 kb)
An 11-year-old boy with peripheral nervous system vasculitis associated with Churg-Strauss syndrome (Fig. 41.9). The video shows the asymmetric involvement of the lower limbs with right foot drop and high steppage gait (MOV 1567 kb)
High steppage gait, pes planus, and foot drop in 2.5-year-old twins who have CMT4A due to GDAP1 gene mutation (AVI 9962 kb)
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Salih, M.A.M., Azzedine, H. (2020). Peripheral Nerve Disorders. In: Salih, M.A. (eds) Clinical Child Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-43153-6_41
Download citation
DOI: https://doi.org/10.1007/978-3-319-43153-6_41
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43152-9
Online ISBN: 978-3-319-43153-6
eBook Packages: MedicineMedicine (R0)